Differences in the behavior of two line C57BL/6 and BALB/C mice in the "open field" test in the background of pregabalin

V. Kashkin, ORCID 0000-0002-7202-0233

Research-and-manufacturing company «Home оf Pharmacy»,
3, bild. 245, Zavodskaya St., Kuzmolovskiy, Vsevolozhskiy district, Leningrad region, 188663, Russia

Е-mail: kashkinv@gmail.com


The aim of this study was to evaluate the behavior of mice of two inbred strains C57Bl/6 and BALB/c in the “open field” test, as well as the effect of the drug with anxiolytic activity Lyrica® (INN: pregabalin) on their behavior under test conditions. The experiment used 20 male mice of the strain C57Bl and 20 male mice of the strain BALB/c. Pregabalin was administered intragastrically during 14 days in dose 10 mg/kg. Control animals received vehicle in a volume corresponding to the volume of drug administration. The “open field” test was performed on the 14th day of administration (1 hour after the administration of pregabalin and the vehicle); the duration of testing for each animal was 5 minutes. The approximate research activity of the animals was assessed by a number of elementary motor acts and postures, the totality of which characterizes integral behavior during testing in the "open field" test. The following indicators were including: the number of crossed squares in the periphery; the number of central squares entries; the number of rearing; the number of nose-poke; the number of urination and defecation. The analysis of the obtained results showed that in C57Bl/6 mice with a predominance of the active type of behavior, the drug "Lyrica®", when administered for 14 days, had a weak anxiolytic effect, which was of a sedative feature. In contrast, in BALB/c mice with a predominantly passive type of behavior, course administration of pregabalin had a pronounced anti-anxiety effect, which was characterized by an increase in active behavior and exploratory activity responses to novelty or anxiogenic environment in the test. The results obtained in two inbred strains of mice with different behavioral phenotypes (response to stress) may help to identify the genetic and biological bases of strategies for coping with stress in humans. In the future, such data may contribute to a more personalized approach to the treatment of neurotic syndromes in patients with depressive-like behavior. 

Full text avaliable in Russain only.


  1. Руководство по проведению доклинических исследований лекарственных средств. Часть первая. / под ред. Миронов А. Н. ‒ 2012. ‒ М. Гриф и К, 944 с [Rukovodstvo po provedeniyu doklinicheskikh issledovanii lekarstvennykh sredstv. Chast' pervaya. / pod red. Mironov A. N. ‒ 2012. ‒ M. Grif i K, 944 p. (In Russ.)].
  2. Lalonde R., Strazielle C. Relations between open-field, elevated plus-maze, and emergence tests in C57BL/6J and BALB/c mice injected with GABA- and 5HT-anxiolytic agents // Fundam Clin Pharmacol. ‒ 2010. ‒ V. 24, No 3. ‒ P. 365-76. http://doi.org/10.1111/j.1472-8206.2009.00772.x
  3. Середенин С. Б., Ведерников А. А. Влияние психотропных препаратов на поведение линейных мышей в условиях эмоционального стресса // Бюлл. экспер. биол. и мед. ‒ 1979. ‒ Т. 88, № 7. ‒ С. 38-40.
  4. Tang X., Xiao J., Parris B. S., Fang J., Sanford L. D. Differential effects of two types of environmental novelty on activity and sleep in BALB/cJ and C57BL/6J mice // Physiology & Behavior. ‒ 2005. ‒ V. 85, No 4. ‒ P. 419-429. http://doi.org/10.1016/j.physbeh.2005.05.008
  5. Belliotti T. R., Capiris T., Ekhato I. V., Kinsora J. J., Field M. J., Heffner T. G., Meltzer L. T., Schwarz J. B., Taylor C. P., Thorpe A. J., Vartanian M. G., Wise L. D., Zhi-Su T., Weber M. L., Wustrow D. J. Structure-activity relationships of pregabalin and analogues that target the alpha(2)-delta protein // J Med Chem. ‒ 2005. ‒ V. 48, No 7. ‒ P. 2294-307. http://doi.org/10.1021/jm049762l
  6. Field M. J., Oles R. J., Singh L. Pregabalin may represent a novel class of anxiolytic agents with a broad spectrum of activity // British Journal of Pharmacology. ‒ 2001. ‒ V. 132, No 1. ‒ P. 1-4. http://doi.org/10.1038/sj.bjp.0703794
  7. Zohar J., Matar M. A., Ifergane G., Kaplan Z., Cohen H. Brief post-stressor treatment with pregabalin in an animal model for PTSD: short-term anxiolytic effects without long-term anxiogenic effect // Eur Neuropsychopharmacol. ‒ 2008. ‒ V. 18, No 9. ‒ P. 653-66. http://doi.org/10.1016/j.euroneuro.2008.04.009
  8. van Meer P., Raber J. Mouse behavioural analysis in systems biology // Biochemical Journal. ‒ 2005. ‒ V. 389, No 3. ‒ P. 593-610. http://doi.org/10.1042/bj20042023
  9. Post A. M., Weyers P., Holzer P., Painsipp E., Pauli P., Wultsch T., Reif A., Lesch K.-P. Gene–environment interaction influences anxiety-like behavior in ethologically based mouse models // Behavioural Brain Research. ‒ 2011. ‒ V. 218, No 1. ‒ P. 99-105. http://doi.org/10.1016/j.bbr.2010.11.031
  10. Crawley J. N. Unusual behavioral phenotypes of inbred mouse strains // Trends in Neurosciences. ‒ 1996. ‒ V. 19, No 5. ‒ P. 181-182. http://doi.org/10.1016/S0166-2236(96)20021-9
  11. Crawley J. N., Belknap J. K., Collins A., Crabbe J. C., Frankel W., Henderson N., Hitzemann R. J., Maxson S. C., Miner L. L., Silva A. J., Wehner J. M., Wynshaw-Boris A., Paylor R. Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies // Psychopharmacology. ‒ 1997. ‒ V. 132, No 2. ‒ P. 107-124. http://doi.org/10.1007/s002130050327
  12. Tannenbaum B., Anisman H. Impact of chronic intermittent challenges in stressor-susceptible and resilient strains of mice // Biol Psychiatry. ‒ 2003. ‒ V. 53, No 4. ‒ P. 292-303.
  13. Heredia L., Torrente M., Colomina M. T., Domingo J. L. Assessing anxiety in C57BL/6J mice: A pharmacological characterization of the zero maze test // Journal of Pharmacological and Toxicological Methods. ‒ 2013. ‒ V. 68, No 2. ‒ P. 275-283. http://doi.org/10.1016/j.vascn.2013.02.010
  14. Heredia L., Torrente M., Colomina M. T., Domingo J. L. Assessing anxiety in C57BL/6J mice: A pharmacological characterization of the open-field and light/dark tests // Journal of Pharmacological and Toxicological Methods. ‒ 2014. ‒ V. 69, No 2. ‒ P. 108-114. http://doi.org/10.1016/j.vascn.2013.12.005
  15. Lapitskaia A. S., Kudrin V. S. P.3.019 Interstrain differences in neurotransmitters response in BALB/c and C57BI/6 mice after open field stress // European Neuropsychopharmacology ‒ V. 15. ‒ P. S150-S151. http://doi.org/10.1016/S0924-977X(05)80315-3
  16. Seredenin S. B., Nadorova A. V., Kolik L. G., Yarkova M. A. Effects of phenazepam on the behavior of C57BL/6 and BALB/c mice in the open field test after naloxone pretreatment // Bull Exp Biol Med. ‒ 2013. ‒ V. 155, No 3. ‒ P. 346-9.
  17. Belzung C., Lemoine M. Criteria of validity for animal models of psychiatric disorders: focus on anxiety disorders and depression // Biology of Mood & Anxiety Disorders. ‒ 2011. ‒ V. 1, No 1. ‒ P. 9. http://doi.org/10.1186/2045-5380-1-9
  18. Cunningham M. O., Woodhall G. L., Thompson S. E., Dooley D. J., Jones R. S. Dual effects of gabapentin and pregabalin on glutamate release at rat entorhinal synapses in vitro // Eur J Neurosci. ‒ 2004. ‒ V. 20, No 6. ‒ P. 1566-76. http://doi.org/10.1111/j.1460-9568.2004.03625.x
  19. Bayer K., Ahmadi S., Zeilhofer H. U. Gabapentin may inhibit synaptic transmission in the mouse spinal cord dorsal horn through a preferential block of P/Q-type Ca2+ channels // Neuropharmacology. ‒ 2004. ‒ V. 46, No 5. ‒ P. 743-9. http://doi.org/10.1016/j.neuropharm.2003.11.010
  20. Seredenin S. B., Blednov Yu A., Badyshtov B. A., Gordey M. L., Nagovitsina Y. A. Pharmacogenetic analysis of mechanisms of emotional stress: effects of benzodiazepines // Ann Ist Super Sanita. ‒ 1990. ‒ V. 26, No 1. ‒ P. 81-7.
  21. Thompson T., Grabowski-Boase L., Tarantino L. M. Prototypical anxiolytics do not reduce anxiety-like behavior in the open field in C57BL/6J mice // Pharmacol Biochem Behav. ‒ 2015. ‒ V. 133. ‒ P. 7-17. http://doi.org/10.1016/j.pbb.2015.03.011
  22. Stress, appraisal, and coping / Lazarus R. S., Folkman S. ‒ New York: Springer Pub. Co., 1984.

You may be interested